Brand-name market exclusivity for nebulizer therapy to treat asthma and COPD
This work was funded by the Commonwealth Fund, as well as from a grant to W.B.F. A.S.K.’s work was also supported by Arnold Ventures. R.B.’s work is funded by an O’Brien Institute of Public Health catalyst grant for equitable pharmaceutical innovation and access to medicines. The funders had no role in the design and conduct of the study; collection, management, analysis or interpretation of the data; review or approval of the manuscript; or decision to submit the manuscript for publication.
Department of Community Health Sciences, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada
Ireland Latest News, Ireland Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Can Psilocybin Help Individuals With Alcohol Dependence?As research on psychedelics marches on, a new study finds a potentially promising use: treating alcoholism. Here's what the researchers found.
Read more »
RETHINC Takes Air Out of COPD-like Therapy for SmokersBronchodilator therapy was no better than placebo at reducing respiratory symptoms in smokers. ERSCongress
Read more »
Episode 3: Novel Therapies in Severe Asthma TreatmentDrs Wechsler and pakuthot discuss novel therapies in severe asthma treatment, including precision medicine, biomarkers, and new biologic agents.
Read more »
Monkeypox response relies on three vaccine suppliers - Nature BiotechnologyBiodefense stockpiles are helping to curb the monkeypox outbreak, but the vaccines are based on old technology with significant side effects. Are other vaccines on the horizon?
Read more »
A combined stem-cell–gene therapy strategy for ALS - Nature MedicineNews & Views: Scientists developed a combined stem-cell and genetherapy strategy for ALS. Hideyuki Okano discusses the first clinical results, which will inform further clinical trials of this neurodegenerative disease. MIT mcgovernmit KeioGlobal
Read more »